Hospira Recalls Buprenorphine Injections Due to Impurity Issues
Hospira Inc. recalls specific lots of Buprenorphine Hydrochloride Injection due to failed impurity specifications. Check lot numbers and expiration dates for details.
Use caution until it’s fixed
Failed Impurities/Degradation Specification: Out of Specification results for pseudobuprenorphine impurity at the 9-month stability time point.
Contact the company
What happened, in plain English
Hospira Inc. is recalling Buprenorphine Hydrochloride Injection, a controlled substance used for pain management or addiction treatment. The recall was initiated because testing showed out-of-specification results for the pseudobuprenorphine impurity at the 9-month stability time point. This means the drug may not meet its established quality standards for purity. Read more at govinfonow.com/recall/45764-hospira-inc-recalls-buprenorphine-hydrochloride-injection-ciii-0-3-mg.
Source Summary by GovInfoNow · govinfonow.com/recall/45764-hospira-inc-recalls-buprenorphine-hydrochloride-injection-ciii-0-3-mg · Updated October 12, 2026 · FDA enforcement record: FDA #D-1604-2014
Cite this page
“Hospira Recalls Buprenorphine Injections Due to Impurity Issues.” GovInfoNow, updated October 12, 2026. https://govinfonow.com/recall/45764-hospira-inc-recalls-buprenorphine-hydrochloride-injection-ciii-0-3-mg. Based on FDA recall #D-1604-2014 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1604-2014%22&limit=1).
Why it’s dangerous
The product failed to meet specifications for pseudobuprenorphine impurity levels during stability testing. While the specific health effects of this impurity are not detailed in the record, deviations from purity standards can potentially affect the safety or efficacy of the medication.
Who’s affected
Patients who have been prescribed or received Buprenorphine Hydrochloride Injection from Hospira Inc. between the manufacturing date and the expiration date of February 1, 2015. Healthcare providers administering this drug are also affected.
How to tell if you have this one
Check if you have Buprenorphine Hydrochloride Injection, CIII, 0.3 mg base/mL, 1 mL, in 10 Carpuject Sterile Cartridge Units with Luer Lock Slim-Paks. Look for Lot Numbers 35-730-LL or 35-745-LL and an expiration date of 1 FEB 2015. The NDC is 0409-2012-32.
- Brand
Hospira- Category
Drug
What to do — step by step
Check Your Lot Numbers
Verify if your medication matches the recalled lot numbers 35-730-LL or 35-745-LL and expiration date of 1 FEB 2015.
Contact Your Healthcare Provider
Consult your doctor or pharmacist immediately to discuss alternative treatments or next steps for your care.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 2.5 years after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Questions people ask
Where was this product sold?
The product was distributed nationwide in the United States.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-1604-2014 (September 9, 2014) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1604-2014 to see it in context.
- Plain-language summary written by qwen3.6:35b-a3b on October 12, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.